CoChat

Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy

Adhikari, Nilanjan, Jha, Tarun, Ghosh, Balaram · 2021 · Journal of Medicinal Chemistry

The DOI matches its Crossref record; 307 of the 308 references it cites were found in a registry or an index.

Abstract

The acetylation of histone and non-histone proteins has been implicated in several disease states. Modulation of such epigenetic modifications has therefore made histone deacetylases (HDACs) important drug targets. HDAC3, among various class I HDACs, has been signified as a potentially validated target in multiple diseases, namely, cancer, neurodegenerative diseases, diabetes, obesity, cardiovascular disorders, autoimmune diseases, inflammatory diseases, parasitic infections, and HIV. However, only a handful of HDAC3-selective inhibitors have been reported in spite of continuous efforts in design and development of HDAC3-selective inhibitors. In this Perspective, the roles of HDAC3 in various diseases as well as numerous potent and HDAC3-selective inhibitors have been discussed in detail. It will surely open up a new vista in the discovery of newer, more effective, and more selective HDAC3 inhibitors.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.0c01676

Cites

307 of 307 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

2 retracted

Items 201–307 of 307

Research works printed but not linked: 3

  1. Liu L. T., 2003, Cancer Res., 63, 3069
  2. Terui T., 2003, Cancer Res., 63, 8948
  3. Xu Y., 2005, Int. J. Mol. Med., 15, 169

Cited by

See all 76

Metadata

Authors
Adhikari, N., Jha, T., & Ghosh, B.
Affiliations
  • Jadavpur University (IN)
  • Birla Institute of Technology and Science - Hyderabad Campus (IN)
Corresponding author
  • Jha, Tarun
  • Ghosh, Balaram
Venue
Journal of Medicinal Chemistry
Published
2021-06-23
Volume
64
Issue
13
Pages
8827-8869
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W3176448552
Cited by
74
References
308
Citations by year
2026: 16 · 2025: 14 · 2024: 18 · 2023: 15 · 2022: 8 · 2021: 3
FWCI
1.21
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Council of Scientific and Industrial Research (09/096(0966)/2019-EMR-I, CSIR- 37(1722)/19/EMR-II)
  • University Grants Commission
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
Keywords
HDAC3, histone acetylation, non-histone protein acetylation, epigenetic drug targets, cancer, neurodegenerative diseases, diabetes mellitus, obesity, cardiovascular disease, autoimmune disease, inflammatory diseases, parasitic infection, HIV, inhibitor design
MeSH terms
Histone Deacetylase 3, Autoimmune Diseases, Cardiovascular Diseases, Diabetes Mellitus, Histone Deacetylases, Humans, Neoplasms, Obesity, HIV Infections, Neurodegenerative Diseases, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.